4552.T
JCR Pharmaceuticals Co.,Ltd.
プライム · 医薬品 · 医薬品 · JP
JPY 527.00
+0.76%Year over year
Reported trailing growth
- Revenue
- +21.9%
- EBITDA
- —
- EBIT
- +108.3%
- EPS
- +146.5%
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- -2.0%
- EBITDA
- —
- EPS
- -26.6%
Three-year CAGR
- Revenue
- +5.5%
- EBITDA
- -23.6%
- EBIT
- -51.9%
- Net income
- -16.7%
- EPS
- -16.2%
- Free cash flow
- +24.8%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026